slides · global inventory
Source Note
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 110,355
Current window 56,941-56,970
Pages 3,679
Rows per page 30
Component
56,941-56,970 of 110,355
49
The slide uses a timeline framework to demonstrate clinical efficacy over time.AstraZeneca | Investor Day Presentation Deck | 86 slides · AstraZeneca
Conference presentation Investor relations 1 hit
50
The chart shows revenue split between US and Ex-US markets.AstraZeneca | Investor Day Presentation Deck | 86 slides · AstraZeneca
Conference presentation Investor relations 1 hit
52
Slide 6 of a presentation. Combines patient demographics, clinical trial results (DIALIZE), and revenue growth.AstraZeneca | Investor Day Presentation Deck | 86 slides · AstraZeneca
Conference presentation Investor relations 1 hit
54
The slide uses a process-oriented layout to map drug development stages to a timeline of upcoming news events.AstraZeneca | Investor Day Presentation Deck | 86 slides · AstraZeneca
Conference presentation Investor relations 1 hit
62
The slide uses a three-column layout to present quantitative data points for each disease category, supported by footnotes.AstraZeneca | Investor Day Presentation Deck | 86 slides · AstraZeneca
Conference presentation Investor relations 1 hit
63
The slide uses a three-column layout to categorize strategic focus areas.AstraZeneca | Investor Day Presentation Deck | 86 slides · AstraZeneca
Conference presentation Investor relations 1 hit
64
The slide uses a combination of a biological pathway diagram and a violin plot to demonstrate drug efficacy.AstraZeneca | Investor Day Presentation Deck | 86 slides · AstraZeneca
Conference presentation Investor relations 1 hit
65
Includes longitudinal pharmacodynamic data for IL5 and IL13 reduction and a list of Phase II trials with patient counts and timelines.AstraZeneca | Investor Day Presentation Deck | 86 slides · AstraZeneca
Conference presentation Investor relations 1 hit
66
The slide uses a combination of line charts and bar charts to demonstrate efficacy, alongside a molecular pathway diagram.AstraZeneca | Investor Day Presentation Deck | 86 slides · AstraZeneca
Conference presentation Investor relations 1 hit
67
Includes line chart for pain scores over time, forest plot for NGF suppression efficacy, and trial status list.AstraZeneca | Investor Day Presentation Deck | 86 slides · AstraZeneca
Conference presentation Investor relations 1 hit
75
The slide uses a three-column layout to contrast disease statistics with clinical evidence for treatment.AstraZeneca | Investor Day Presentation Deck | 86 slides · AstraZeneca
Conference presentation Investor relations 1 hit
76
Slide uses a split-layout comparing two distinct product strategies (COPD vs Asthma).AstraZeneca | Investor Day Presentation Deck | 86 slides · AstraZeneca
Conference presentation Investor relations 1 hit
77
The slide uses a combination of donut charts for market penetration and a grouped bar chart for clinical trial efficacy data.AstraZeneca | Investor Day Presentation Deck | 86 slides · AstraZeneca
Conference presentation Investor relations 1 hit
78
The slide uses a matrix-like structure to map biological mechanisms to specific drug candidates and development timelines.AstraZeneca | Investor Day Presentation Deck | 86 slides · AstraZeneca
Conference presentation Investor relations 1 hit
79
The slide uses a three-column layout to present distinct clinical trial outcomes.AstraZeneca | Investor Day Presentation Deck | 86 slides · AstraZeneca
Conference presentation Investor relations 1 hit
03
The slide uses a matrix structure to map drug candidates against development stages.Bausch Health Companies | Investor Conference Presentation Deck | 10 slides · Bausch Health
Conference presentation Investor relations Beat · Problem1 hit
10
The slide uses a grid-based timeline layout to track multiple drug development programs simultaneously.Bausch Health Companies | Investor Conference Presentation Deck | 10 slides · Bausch Health
Conference presentation Investor relations Loop · Why Now1 hit
06
The slide uses a 2x3 grid layout to present organizational milestones.BioNTech | Results Presentation Deck | 36 slides · BioNTech
Conference presentation Investor relations Beat · Key Takeaways1 hit
11
Includes citations for clinical trial data.BioNTech | Results Presentation Deck | 36 slides · BioNTech
Conference presentation Investor relations Beat · RoadmapLoop · Why Now1 hit
12
The slide highlights vaccine efficacy metrics (97% and 94%) against various COVID-19 outcomes.BioNTech | Results Presentation Deck | 36 slides · BioNTech
Conference presentation Investor relations Beat · RoadmapLoop · Why Now1 hit
19
The slide uses a timeline-style visual representation within a table structure to show development stages.BioNTech | Results Presentation Deck | 36 slides · BioNTech
Conference presentation Investor relations Beat · Timeline1 hit
21
Includes a citation of a Science paper and a structural diagram of the CAR construct.BioNTech | Results Presentation Deck | 36 slides · BioNTech
Conference presentation Investor relations Beat · Timeline1 hit
22
The slide uses a process diagram to show production and a combination of anatomical illustration and a line chart to show the mechanism of action and therapeutic effect.BioNTech | Results Presentation Deck | 36 slides · BioNTech
Conference presentation Investor relations Beat · Timeline1 hit
23
The slide uses a process flow diagram to illustrate the trial structure from patient selection to expansion cohorts.BioNTech | Results Presentation Deck | 36 slides · BioNTech
Conference presentation Investor relations 1 hit
24
The slide uses a comparison framework to contrast the pharmacokinetic profile of recombinant cytokines (spiky) vs RiboCytokines (sustained).BioNTech | Results Presentation Deck | 36 slides · BioNTech
Conference presentation Investor relations 1 hit
25
The diagram uses a staircase visual for dose levels and horizontal arrows for expansion cohorts.BioNTech | Results Presentation Deck | 36 slides · BioNTech
Conference presentation Investor relations 1 hit
28
The chart uses a stacked bar to decompose total revenue into four distinct categories, with a bracket highlighting the COVID-19 specific portion.BioNTech | Results Presentation Deck | 36 slides · BioNTech
Conference presentation Investor relations Beat · Appendix Data1 hit
30
Includes footnote clarifying tax loss carryforwards.BioNTech | Results Presentation Deck | 36 slides · BioNTech
Conference presentation Investor relations Beat · Appendix Data1 hit
36
This is a standard closing/contact slide.BioNTech | Results Presentation Deck | 36 slides · BioNTech
Conference presentation Investor relations 1 hit
04
Cano Health | SPAC Presentation Deck | 77 slidesCano Health | SPAC Presentation Deck | 77 slides · Cano Health
Conference presentation Investment bank 1 hit